Dilon Diagnostics out of Newport News, Virginia has won FDA marketing approval for its GammaLōc breast biopsy localization tool. The system is used with a gamma ray camera to take two images 20 degrees from the left and right side of the breast. The software then triangulates the location of the tissue region in question.
GammaLōc® is a complementary technology to Dilon’s cornerstone product, the Dilon 6800® Gamma Camera. The GammaLōc® (GL) system will help doctors accurately locate breast lesions and enable gamma-guided biopsies, particularly useful for patients that have findings on the Dilon system that are not revealed with other imaging modalities.
The GammaLōc® system utilizes a CorreLocator™ paddle and a StereoView™ imaging collimator system – a technique similar to that used in stereotactic X-ray localization, and the GammaLōc® software calculates the specific location of the suspect lesion. The compact design allows for breast biopsies with optimal patient comfort; and the entire system is small and portable, allowing physicians to perform molecular imaging guided biopsy procedures anywhere on site.
The GammaLōc® system utilizes a CorreLocator™ paddle and a StereoView™ imaging collimator system – a technique similar to that used in stereotactic X-ray localization, and the GammaLōc® software calculates the specific location of the suspect lesion. The compact design allows for breast biopsies with optimal patient comfort; and the entire system is small and portable, allowing physicians to perform molecular imaging guided biopsy procedures anywhere on site.Press release: Dilon Diagnostics Gamma-Guided Localization System Cleared by FDA…
Product page: The GammaLōc® System…